JOE / USDT

NOM / USDT

NOM / TRY

ZEC / U

ZEC / USD1

ZEC / USDT

ZEC / USDC

ZEC / BTC

ZEC / ETH

KMNO / USDC

DEGO / USDT

DEXE / USDT

BANK / USDC

BANK / USDT

BANK / TRY

STO / USDC

STO / USDT

STO / TRY

HFT / USDT

C / TRY

ALKALI METALS LTD

SONA MACHINERY LIMITED

CLASSIC ELECTRODE (IND) L

ALPHAGEO (INDIA) LIMITED

LIKHITHA INFRASTRUC LTD

CYBERTECH SYSTEMS & SOFTW

UMA EXPORTS LIMITED

LANDMARK PR.DEV.CO.LTD

DIENSTEN TECH LIMITED

ACCURACY SHIPPING LIMITED

RAJ TV NETWORK LTD

SUNREST LIFESCIENCE LTD

JUBILANT FOODWORKS LTD

AMIR CHAND JAG KUM (E) L

ENERGY MISSION MACH IND L

M.V.K. AGRO FOOD PROD LTD

PACE DIGITEK LIMITED

MARUSHIKA TECHNOLOGY LTD

ENTERO HEALTHCARE SOLU L

FORCE MOTORS LIMITED

Click here to get full coverage on SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals - simplywall.st

SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals  simplywall.st

SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals - simplywall.st

Click here to get full coverage on SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - Medical Dialogues

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case  Medical Dialogues

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - Medical Dialogues

Click here to get full coverage on SMS Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics - Markets Mojo

SMS Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics  Markets Mojo

SMS Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics - Markets Mojo

Click here to get full coverage on SMS Pharma Shares Surge 12% on 74% Profit Jump in Q2FY26 - HDFC Sky

SMS Pharma Shares Surge 12% on 74% Profit Jump in Q2FY26  HDFC Sky

SMS Pharma Shares Surge 12% on 74% Profit Jump in Q2FY26 - HDFC Sky

Click here to get full coverage on SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets - Business Standard

SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets  Business Standard

SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets - Business Standard

Click here to get full coverage on SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm - The Hindu

SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm  The Hindu

SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm - The Hindu

Click here to get full coverage on Market Participants Recognise SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Earnings Pushing Shares 31% Higher - simplywall.st

Market Participants Recognise SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Earnings Pushing Shares 31% Higher  simplywall.st

Market Participants Recognise SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Earnings Pushing Shares 31% Higher - simplywall.st

Click here to get full coverage on SMS Pharma’s associate firm gets USFDA nod for Ranitidine tablets - thehindubusinessline.com

SMS Pharma’s associate firm gets USFDA nod for Ranitidine tablets  thehindubusinessline.com

SMS Pharma’s associate firm gets USFDA nod for Ranitidine tablets - thehindubusinessline.com

Click here to get full coverage on SMS Pharma Shares Skyrocket 10% on EIR from USFDA - Equitypandit

SMS Pharma Shares Skyrocket 10% on EIR from USFDA  Equitypandit

SMS Pharma Shares Skyrocket 10% on EIR from USFDA - Equitypandit

Click here to get full coverage on SMS Pharmaceuticals shares soar 17% after USFDA approves reformulated Ranitidine tablets - Mint

SMS Pharmaceuticals shares soar 17% after USFDA approves reformulated Ranitidine tablets  Mint

SMS Pharmaceuticals shares soar 17% after USFDA approves reformulated Ranitidine tablets - Mint

Click here to get full coverage on Buzzing Stocks: Drugmaker gains most in five years after regulator approves re-entry of key drug - cnbctv18.com

Buzzing Stocks: Drugmaker gains most in five years after regulator approves re-entry of key drug  cnbctv18.com

Buzzing Stocks: Drugmaker gains most in five years after regulator approves re-entry of key drug - cnbctv18.com

Click here to get full coverage on SMS Pharma Shares Rise On USFDA Ranitidine Approval - Samco

SMS Pharma Shares Rise On USFDA Ranitidine Approval  Samco

SMS Pharma Shares Rise On USFDA Ranitidine Approval - Samco

Click here to get full coverage on SMS Pharma Q3 Profit Soars 36%, Invests ₹7 Cr in Unit - Whalesbook

SMS Pharma Q3 Profit Soars 36%, Invests ₹7 Cr in Unit  Whalesbook

SMS Pharma Q3 Profit Soars 36%, Invests ₹7 Cr in Unit - Whalesbook

Click here to get full coverage on Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL,... - Moneycontrol.com

Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL,...  Moneycontrol.com

Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL,... - Moneycontrol.com

Click here to get full coverage on SMS Pharma Surges 10% on USFDA Nod, Ends 3.85% Lower - HDFC Sky

SMS Pharma Surges 10% on USFDA Nod, Ends 3.85% Lower  HDFC Sky

SMS Pharma Surges 10% on USFDA Nod, Ends 3.85% Lower - HDFC Sky

Click here to get full coverage on Sharda Crop, SMS Pharma among top analyst bets; check target, stop-loss - Business Standard

Sharda Crop, SMS Pharma among top analyst bets; check target, stop-loss  Business Standard

Sharda Crop, SMS Pharma among top analyst bets; check target, stop-loss - Business Standard

Click here to get full coverage on SMS Pharma spurts after Q2 PAT climbs 79% YoY to Rs 25 cr - Business Standard

SMS Pharma spurts after Q2 PAT climbs 79% YoY to Rs 25 cr  Business Standard

SMS Pharma spurts after Q2 PAT climbs 79% YoY to Rs 25 cr - Business Standard

Click here to get full coverage on SMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical Services - Medical Dialogues

SMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical Services  Medical Dialogues

SMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical Services - Medical Dialogues

Click here to get full coverage on SMS Pharma spurts after associate firm secures USFDA nod for reformulated Ranitidine tablets - Business Standard

SMS Pharma spurts after associate firm secures USFDA nod for reformulated Ranitidine tablets  Business Standard

SMS Pharma spurts after associate firm secures USFDA nod for reformulated Ranitidine tablets - Business Standard

Click here to get full coverage on SMS Pharma Shares Skyrocketed 17% as Arm Secured USFDA Approval - Equitypandit

SMS Pharma Shares Skyrocketed 17% as Arm Secured USFDA Approval  Equitypandit

SMS Pharma Shares Skyrocketed 17% as Arm Secured USFDA Approval - Equitypandit

Click here to get full coverage on SMS Pharma Shares Surge 6% on 0 Observations from USFDA - Equitypandit

SMS Pharma Shares Surge 6% on 0 Observations from USFDA  Equitypandit

SMS Pharma Shares Surge 6% on 0 Observations from USFDA - Equitypandit

Click here to get full coverage on SMS Pharma's Hyderabad Lab Receives FDA Clearance with 'No Action Indicated' Status - scanx.trade

SMS Pharma's Hyderabad Lab Receives FDA Clearance with 'No Action Indicated' Status  scanx.trade

SMS Pharma's Hyderabad Lab Receives FDA Clearance with 'No Action Indicated' Status - scanx.trade

Click here to get full coverage on SMS Pharma Surges on 21% Revenue Growth, Margin Boost from Integration - Whalesbook

SMS Pharma Surges on 21% Revenue Growth, Margin Boost from Integration  Whalesbook

SMS Pharma Surges on 21% Revenue Growth, Margin Boost from Integration - Whalesbook

Click here to get full coverage on SMS Pharma Standalone December 2025 Net Sales at Rs 210.45 crore, up 21.4% Y-o-Y - Moneycontrol.com

SMS Pharma Standalone December 2025 Net Sales at Rs 210.45 crore, up 21.4% Y-o-Y  Moneycontrol.com

SMS Pharma Standalone December 2025 Net Sales at Rs 210.45 crore, up 21.4% Y-o-Y - Moneycontrol.com

Click here to get full coverage on Sms Pharmaceuticals Stock Price Forecast. Should You Buy SMSPHARMA.NS? - StockInvest.us

Sms Pharmaceuticals Stock Price Forecast. Should You Buy SMSPHARMA.NS?  StockInvest.us

Sms Pharmaceuticals Stock Price Forecast. Should You Buy SMSPHARMA.NS? - StockInvest.us

Click here to get full coverage on SMS Pharma Sees Revision in Market Evaluation Amidst Strong Financial Indicators - Markets Mojo

SMS Pharma Sees Revision in Market Evaluation Amidst Strong Financial Indicators  Markets Mojo

SMS Pharma Sees Revision in Market Evaluation Amidst Strong Financial Indicators - Markets Mojo

Click here to get full coverage on SMS Pharmaceuticals Q2 | Profit rises 76% YoY to ₹25.14 crore on operational performance - cnbctv18.com

SMS Pharmaceuticals Q2 | Profit rises 76% YoY to ₹25.14 crore on operational performance  cnbctv18.com

SMS Pharmaceuticals Q2 | Profit rises 76% YoY to ₹25.14 crore on operational performance - cnbctv18.com

Click here to get full coverage on SMS Pharma Receives 'No Action Indicated' Status from USFDA for Hyderabad Laboratory - scanx.trade

SMS Pharma Receives 'No Action Indicated' Status from USFDA for Hyderabad Laboratory  scanx.trade

SMS Pharma Receives 'No Action Indicated' Status from USFDA for Hyderabad Laboratory - scanx.trade

Click here to get full coverage on Vistra ITCL Releases 1.06 Crore Pledged Shares of SMS Pharmaceuticals - scanx.trade

Vistra ITCL Releases 1.06 Crore Pledged Shares of SMS Pharmaceuticals  scanx.trade

Vistra ITCL Releases 1.06 Crore Pledged Shares of SMS Pharmaceuticals - scanx.trade

Click here to get full coverage on SMSPHARMA Share Price | SMS Pharmaceuticals Ltd Stock Analysis & Recommendation - Markets Mojo

SMSPHARMA Share Price | SMS Pharmaceuticals Ltd Stock Analysis & Recommendation  Markets Mojo

SMSPHARMA Share Price | SMS Pharmaceuticals Ltd Stock Analysis & Recommendation - Markets Mojo

Click here to get full coverage on SMS Pharmaceuticals Clears USFDA Inspection at Vizag API Facility With One Observation - India Infoline

SMS Pharmaceuticals Clears USFDA Inspection at Vizag API Facility With One Observation  India Infoline

SMS Pharmaceuticals Clears USFDA Inspection at Vizag API Facility With One Observation - India Infoline

Click here to get full coverage on SMS Pharmaceuticals Ltd Hits Intraday High with 9.32% Surge on 12 Feb 2026 - Markets Mojo

SMS Pharmaceuticals Ltd Hits Intraday High with 9.32% Surge on 12 Feb 2026  Markets Mojo

SMS Pharmaceuticals Ltd Hits Intraday High with 9.32% Surge on 12 Feb 2026 - Markets Mojo

Click here to get full coverage on SMS Pharmaceuticals Gets USFDA Clearance for Hyderabad Lab With NAI Status - India Infoline

SMS Pharmaceuticals Gets USFDA Clearance for Hyderabad Lab With NAI Status  India Infoline

SMS Pharmaceuticals Gets USFDA Clearance for Hyderabad Lab With NAI Status - India Infoline

Click here to get full coverage on SMSPHARMA Stock Price and Chart — NSE:SMSPHARMA - TradingView

SMSPHARMA Stock Price and Chart — NSE:SMSPHARMA  TradingView

SMSPHARMA Stock Price and Chart — NSE:SMSPHARMA - TradingView

Click here to get full coverage on Trade Spotlight: How should you trade Lupin, IIFL Finance, Max Financial Services, Adani Ports, SMS... - Moneycontrol.com

Trade Spotlight: How should you trade Lupin, IIFL Finance, Max Financial Services, Adani Ports, SMS...  Moneycontrol.com

Trade Spotlight: How should you trade Lupin, IIFL Finance, Max Financial Services, Adani Ports, SMS... - Moneycontrol.com

Click here to get full coverage on Read This Before You Buy SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Because Of Its P/E Ratio - Yahoo News Malaysia

Read This Before You Buy SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Because Of Its P/E Ratio  Yahoo News Malaysia

Read This Before You Buy SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Because Of Its P/E Ratio - Yahoo News Malaysia

Click here to get full coverage on SMS Pharma Visakhapatnam facility gets WHO Geneva prequalification - Medical Dialogues

SMS Pharma Visakhapatnam facility gets WHO Geneva prequalification  Medical Dialogues

SMS Pharma Visakhapatnam facility gets WHO Geneva prequalification - Medical Dialogues

Click here to get full coverage on SMS Pharmaceuticals Reports 19% Revenue Growth and 24% PAT Increase in Q1 - scanx.trade

SMS Pharmaceuticals Reports 19% Revenue Growth and 24% PAT Increase in Q1  scanx.trade

SMS Pharmaceuticals Reports 19% Revenue Growth and 24% PAT Increase in Q1 - scanx.trade

Click here to get full coverage on Technical Analysis of SMS Pharmaceuticals Limited (NSE:SMSPHARMA) - TradingView

Technical Analysis of SMS Pharmaceuticals Limited (NSE:SMSPHARMA)  TradingView

Technical Analysis of SMS Pharmaceuticals Limited (NSE:SMSPHARMA) - TradingView

Click here to get full coverage on SMS Pharmaceuticals Lists 5 Crore Equity Shares from Warrant Conversion on BSE and NSE - scanx.trade

SMS Pharmaceuticals Lists 5 Crore Equity Shares from Warrant Conversion on BSE and NSE  scanx.trade

SMS Pharmaceuticals Lists 5 Crore Equity Shares from Warrant Conversion on BSE and NSE - scanx.trade

Click here to get full coverage on Pharma stock jumps 10% after USFDA clears company's Hyderabad facility with zero observations - Trade Brains

Pharma stock jumps 10% after USFDA clears company's Hyderabad facility with zero observations  Trade Brains

Pharma stock jumps 10% after USFDA clears company's Hyderabad facility with zero observations - Trade Brains

Click here to get full coverage on SMS Pharmaceuticals’ Vizag plant receives WHO Geneva prequalification - Indian Pharma Post

SMS Pharmaceuticals’ Vizag plant receives WHO Geneva prequalification  Indian Pharma Post

SMS Pharmaceuticals’ Vizag plant receives WHO Geneva prequalification - Indian Pharma Post

Click here to get full coverage on Watch out for these 20 stocks in today’s trade: Hindustan Unilever, PB Fintech, Mobikwik, ONGC, Wheels India, Texmaco Rail, JSW Steel, JSW Energy, NHPC, Tejas Networks, SMS Pharma, Balaji Amines, Adani Total, Signatureglobal, Western Carriers, Solari - thehindubusinessline.com

Watch out for these 20 stocks in today’s trade: Hindustan Unilever, PB Fintech, Mobikwik, ONGC, Wheels India, Texmaco Rail, JSW Steel, JSW Energy, NHPC, Tejas Networks, SMS Pharma, Balaji Amines, Adani Total, Signatureglobal, Western Carriers, Solari  thehindubusinessline.com

Watch out for these 20 stocks in today’s trade: Hindustan Unilever, PB Fintech, Mobikwik, ONGC, Wheels India, Texmaco Rail, JSW Steel, JSW Energy, NHPC, Tejas Networks, SMS Pharma, Balaji Amines, Adani Total, Signatureglobal, Western Carriers, Solari - thehindubusinessline.com

Click here to get full coverage on SMS Pharma receives EDQM certification to supply Ibuprofen in Europe - Indian Pharma Post

SMS Pharma receives EDQM certification to supply Ibuprofen in Europe  Indian Pharma Post

SMS Pharma receives EDQM certification to supply Ibuprofen in Europe - Indian Pharma Post

Click here to get full coverage on SMS Pharma’s Vizag plant receives WHO prequalification - The Hindu

SMS Pharma’s Vizag plant receives WHO prequalification  The Hindu

SMS Pharma’s Vizag plant receives WHO prequalification - The Hindu

Click here to get full coverage on SMS Pharma gets one USFDA observation for Bachupally facility - Medical Dialogues

SMS Pharma gets one USFDA observation for Bachupally facility  Medical Dialogues

SMS Pharma gets one USFDA observation for Bachupally facility - Medical Dialogues

Click here to get full coverage on SMS Pharma revenue down 9% - Indian Pharma Post

SMS Pharma revenue down 9%  Indian Pharma Post

SMS Pharma revenue down 9% - Indian Pharma Post

Click here to get full coverage on SMS Pharma to raise ₹114 crore through warrants issue - thehindubusinessline.com

SMS Pharma to raise ₹114 crore through warrants issue  thehindubusinessline.com

SMS Pharma to raise ₹114 crore through warrants issue - thehindubusinessline.com

Click here to get full coverage on SMS Pharma reports on USFDA articulation on Ranitidine - Microbioz India

SMS Pharma reports on USFDA articulation on Ranitidine  Microbioz India

SMS Pharma reports on USFDA articulation on Ranitidine - Microbioz India

Click here to get full coverage on SMS Pharmaceuticals Share Price Today - Live SMSPHARMA Stock Price for NSE/BSE - Upstox

SMS Pharmaceuticals Share Price Today - Live SMSPHARMA Stock Price for NSE/BSE  Upstox

SMS Pharmaceuticals Share Price Today - Live SMSPHARMA Stock Price for NSE/BSE - Upstox

Click here to get full coverage on SMS Pharma share price rises 13% after USFDA completes inspection with zero observation - Moneycontrol.com

SMS Pharma share price rises 13% after USFDA completes inspection with zero observation  Moneycontrol.com

SMS Pharma share price rises 13% after USFDA completes inspection with zero observation - Moneycontrol.com

Click here to get full coverage on SMS Pharma gets USFDA approval for Andhra unit - Medical Dialogues

SMS Pharma gets USFDA approval for Andhra unit  Medical Dialogues

SMS Pharma gets USFDA approval for Andhra unit - Medical Dialogues

Click here to get full coverage on SMS Pharma's Hyderabad facility clears USFDA inspection - Business Standard

SMS Pharma's Hyderabad facility clears USFDA inspection  Business Standard

SMS Pharma's Hyderabad facility clears USFDA inspection - Business Standard

Click here to get full coverage on SMS Pharma hits new high on USFDA nod for Andhra unit - Business Standard

SMS Pharma hits new high on USFDA nod for Andhra unit  Business Standard

SMSPHARMA

Price Chart

Key Statistics

Technicals

About SMSPHARMA

Latest News

SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals - simplywall.st

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - Medical Dialogues

SMS Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics - Markets Mojo

Advanced Charts

Top Gainers

Top Losers